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1013 [44]. Large bacterial communities are present in a vari-
ety of organs (Table 1). These bacteria are part of the so-
called normal microbiota, and establish commensal or mu-
tualistic relationships with us. Bacterial contributions to 
human health include synthesis of vitamins, detoxification 
of dangerous compounds, adjustment of the immune sys-
tem, and protection against pathogenic microorganisms by 
direct competition [44].
Compared with the thousands of bacterial species that 
are either innocuous or beneficial for us, pathogenic bacteria 
are rare. Furthermore, their involvement in disease is com-
plex, and the view of infectious disease as the attack of one 
organism by another organism is often naive. Bacteria that 
cause disease can be classified in two types. A few species are 
primary (“true”) pathogens. Many others, however, are op-
portunistic pathogens that cause disease in specific circum-
stances only [42]. Environmental, usually harmless species 
can cause disease when a physiological alteration occurs 
PoPular culture views bacteria as enemies of humans, and 
an example is found in a monosyllabic, euphonic poem by 
Catalan writer Joan Oliver (aka Pere Quart):
 
“BACIL
Ni
bri
bo:
microbi.” 
(“BACILLUS: Not good at all: microbe”) [36]. Popular aver-
sion for bacteria is radically opposite to scientific knowl-
edge. Biogeochemical cycles are made possible by bacterial 
metabolism, which recycles molecules and chemical ele-
ments to make life sustainable. Our body is also the home 
for thousands of bacterial species, and the total number of 
bacterial cells in a healthy human may be similar (or even 
exceed) the number of “human” cells: between 1012 and 
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(e.g., a burn or an impairment of innate immunity). Other 
opportunistic pathogens are commensals of the human 
body, and live in an equilibrium sustained by multiple fac-
tors. When the equilibrium is disrupted, the bacterial popu-
lation proliferates and causes disease, sometimes colonizing 
organs where the microorganism is not normally found [42]. 
The distinction between primary and opportunistic 
pathogens is not absolute: upon infection by a primary 
pathogen, certain individuals can be spared from disease by 
genetic or physiological factors. A risky experiment show-
ing that an encounter with a primary pathogen does not 
necessarily lead to disease was performed by German mi-
crobiologist Max von Pettenkoffer in the 19th century. As 
part of his polemics with Robert Koch on the ethiology of 
cholera, Max von Pettenkoffer drank a Vibrio cholerae prep-
aration without suffering contagion [30]. It is also well 
known that epidemics affect certain members of a popula-
tion while others, sometimes in the same family, do not suf-
fer the disease. Genetic polymorphism may be a major 
cause of individual differences in susceptibility to infection, 
as predicted by the Red Queen hypothesis: because patho-
gens prey on the most common host genotypes, a selective 
advantage for rare host genotypes is generated [20]. How-
ever, nutritional and physiological factors have also a major 
impact on host susceptibility to infection.
Evolutionary strategies of pathogens
Despite the multiplicity of factors involved in host-microbe 
interactions, reductionist modeling of host-pathogen interac-
tions is possible. While the Red Queen hypothesis addresses 
the impact of infection on host evolution, classical studies by 
Robert M. May have modeled the evolution of virulence in 
pathogens. A major question, for instance, is whether patho-
gens that evolve to be harmless to their hosts do better than 
those that do not attenuate their virulence. A useful measure 
of pathogen fitness is the reproductive rate, which can be de-
fined as the product of two independent factors: the rate of 
infection of new hosts and the time of host survival after in-
fection [27]. Theoretical analysis of reproductive rates pre-
dicts that evolutionary success can be achieved in many 
manners, and that co-evolution of hosts and parasites can 
follow different paths. If new hosts are efficiently infected, 
host survival will matter little. However, because the number 
of hosts cannot be infinite, high infection rates do not war-
rant long-term success. In fact, lowered levels of host fitness 
can compromise survival of the pathogen if the number of 
hosts decreases below a critical level.
Pathogens that do not attain high rates of infection can 
benefit if the fitness of their hosts is not severely impaired 
upon infection. The longer the host lifespan, the higher the 
reproductive rate. While many viruses (not all) behave as 
“rogue” parasites that increase their reproductive rate at the 
expense of host fitness, many bacterial pathogens seem to in-
crease their reproductive rates by reducing their virulence. 
Self-attenuation of virulence is not only observed in opportu-
nistic pathogens, which cause disease by accident. The evo-
lutionary strategies of primary pathogens also show signs of 
self-attenuation, especially in bacterial species that colonize 
one or a few eukaryotic hosts. In fact, host adaptation and 
attenuation of virulence seem to be related evolutionary pro-
cesses. This kind of evolution converts infectious disease into 
a sort of imperfect symbiosis. This article is mainly centered 
on one primary pathogen, Salmonella enterica, which pres-
ents unequivocal signs of self-restraint during infection of 
animals. Other primary pathogens such as Brucella, Chlamydia, 
Helicobacter, Staphylococcus, and Mycobacterium are also 
known to undergo self-restraint upon infection [38].
An example of primary pathogen: Salmonella
Salmonella enterica is a pathogenic relative of the human 
commensal Escherichia coli. Although the evolutionary di-
vergence between the genera Escherichia and Salmonella 
may have occurred 150 million years ago, their chromo-
somes remain similar [18]. A relevant difference, however, 
is the presence of several pathogenicity islands in the Sal-
monella genome [18]. Genes contained in pathogenicity is-
lands encode type III secretion systems and effector pro-
teins involved in host colonization.
The currenty accepted taxonomy divides the genus Sal-
monella in species, subspecies and serovars. S. enterica sub-
species enterica includes most of the serovars that cause dis-
ease in humans and livestock animals. Serovars 
Typhimurium, Enteriditis, and Typhi are frequently isolat-
ed from humans, and they are associated with an estimated 
115 million clinical cases per year worldwide [11,37]. De-
pending on the serovar and the host, Salmonella infections 
of healthy (immunocompetent) humans can be classified 
into several types. One is gastroenteritis, leading to diar-
Table 1. Mass of bacterial communities in human organs*
Organ/
system
Weight of  
bacterial mass 
(grams, net weight)
Number of  
bacterial cells
Eyes 1 109–1010
Nose 10 1010
Mouth 20 109–1011
Lungs 20 1010
Vagina 20 1010
Skin 200 1010–1011
Intestine 1000 1012
*Adapted from [44].
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cidal action of bile salts. Current evidence suggests that Sal-
monella resistance to bile does not involve a single response 
but a variety of responses. It seems also likely that Salmonel-
la subpopulations are formed upon gall bladder coloniza-
tion, and that these subpopulations respond to bile in differ-
ent ways [3]. A fraction of the Salmonella population invades 
the epithelium, where it may be protected, at least partially, 
from bile salts [28]. Another subpopulation multiplies in 
the gall bladder lumen, either forming biofilms on gallstones 
or activating bile defense responses [10,19]. Biofilm forma-
tion not only contributes to bile resistance but also to anti-
biotic resistance, thereby explaining why patients carrying 
S. Typhi in the gall bladder usually fail to respond to antibi-
otic treatment [17]. In turn, planktonic Salmonella cells sur-
vive in the gall bladder by activating bile defense responses. 
In vitro studies suggest that bile defense may combine acti-
vation of efflux pumps, remodeling of the bacterial enve-
lope, and activation of stress responses and DNA repair 
functions [22,33-35]. Adoption of multiple lifestyles in the 
gall bladder may help to understand the difficulty to eradi-
cate Salmonella chronic carriage, which often makes chole-
cystectomy the only effective treatment.
Stealthy Salmonella persistence inside fibroblasts
The possibility that the gall bladder is not the only reservoir 
for Salmonella Typhi during persistent and chronic infec-
tions has been considered for decades, and has been re-ex-
rhea and inflammation [37]. Gastroenteritis is a mild in-
fection, extremely common in developed countries, and 
involves self-limited infection of the terminal ileum and 
colon. In contrast, typhoid fever is a life-threatening infec-
tion in which Salmonella disseminates through the lym-
phatic system and is transported within phagocytes [11]. 
Dissemination permits colonization of the liver, the spleen, 
the bone marrow, and the gall bladder. Death may occur as 
the consequence of the phenomenon known as septic 
shock, an overeaction of the host immune system triggered 
by Salmonella lipopolysaccharide [43]. In the twentieth 
century, typhoid fever was virtually eradicated in devel-
oped countries by the development of drinking water 
treatment, water sewage control, pasteurization of milk 
and dairy products, and other food technology practices. 
However, typhoid fever remains a major problem for pub-
lic health in developing countries: around 25-30 million 
cases are estimated to occur per year worldwide [11]. 
A fraction of individuals recovering from typhoid fever 
become asymptomatic, life-long carriers of Salmonella en-
terica ser. Typhi [11]. Non-typhoidal Salmonella serovars 
can also cause persistent infections, either associated with 
cholecystitis or asymptomatic, although the duration of car-
riage is usually limited to several months [37]. Persistent 
and chronic infections, especially if asymptomatic, may be 
viewed as evolutionary strategies that increase the Salmonella 
reproductive rate by favoring host survival. Like humans, 
livestock and wild animals can be asymptomatic carriers of 
non-typhoidal Salmonella serovars able to infect humans, 
thus acting as reservoirs for human infection (Fig. 1).
Chronic carriage of Salmonella
Human carriage of Salmonella Typhi is often asymptomatic, 
and therefore difficult to diagnose. At the beginning of the 
twentieth century, a famous case was protagonized by Mary 
Mallon, the first chronic carrier identified in the United 
States. Mallon, an Irish immigrant, is presumed to have in-
fected at least 51 people, three of whom died, over the 
course of her career as a cook in New York [5].
Antibiotics are usually ineffective on Salmonella car-
riage (even if Salmonellae are susceptible to them) because 
Salmonella resides in the gall bladder [17]. Bacterial prolif-
eration in the gall bladder of chronic carriers permits Sal-
monella shedding to the environment, potentially transmit-
ting the infection.
The ability of Salmonella to thrive in the human gall 
bladder is one of most surprising aspects of Salmonella biol-
ogy because the high concentration of bile present in the gall 
bladder makes it a harsh environment for bacteria: bile salts 
disrupt the bacterial envelope, denature proteins, and dam-
age DNA [4,8,29]. However, Salmonella escapes the bacteri-
Fig. 1. A Salmonella enterica cell dividing in the presence of 5 % sodium 
deoxycholate. Survival and division in the presence of bile salts is made 
possible by activation of bile resistance responses [22]. (Electron micros-
copy image obtained by Miguel A. de Pedro, Severo Ochoa Molecular 
Biology Centre (CBMSO), Cantoblanco, Spain).
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amined recently [31]. It seems possible, for instance, that 
Salmonella Typhi may invade cell types other than its classi-
cal cell targets (epithelial cells, dendritic cells and macro-
phages), perhaps adopting a latent intracellular lifestyle. In 
the mouse model of typhoid fever, Salmonella Typhimuri-
um can invade fibroblasts, a ubiquitous cell type with long 
lifespan in connective tissues [38]. Interestingly, coloniza-
tion of fibroblasts by S. Typhimurium is not followed by bac-
terial proliferation. This restrained lifestyle resembles the 
persistent state which in other microorganisms is known as 
dormancy [16]. Persistence of Salmonella inside fibroblasts 
is an example of bacterial self-restraint, as indicated by the 
isolation of S. Typhimurium mutants able to proliferate in-
side fibroblasts [6]. The bacterial functions that restrain 
growth inside fibroblasts are also required for virulence, 
and overgrowth inside fibroblasts does not cause hypervir-
ulence but loss of virulence [15]. Hence, a tentative link 
can be established between successful infection and bacte-
rial self-restraint. The peculiar nature of the Salmonella-fibro-
blast interaction is further illustrated by the fact that inva-
sion of fibroblast cell lines differs from entry into epithelial 
cells, especially in the way the bacterium induces rearrage-
ment of the eukaryotic cytoskeleton [1]. Collectively, these 
findings support the possibility that Salmonella, like other 
intracellular pathogens, may have evolved strategies to 
avoid host damage and to favor stealthy bacterial persis-
tence in host tissues. On the other hand, slow-growing S. 
Typhimurium variants have been isolated upon long-term 
passage through fibroblasts [7], and these mutants resem-
ble the Staphylococcus aureus small colony variants that 
cause chronic infections [41] (Fig. 2).
Attenuation of Salmonella virulence by 
subpopulation formation
Single cell analysis technologies (e.g., flow cytometry and 
microfluidics) reveal that phenotypic heterogeneity is com-
mon in bacterial populations made of genetically identical 
cells [12]. In some cases, formation of bacterial subpopula-
tions is programmed by genetic or epigenetic mechanisms; 
in other cases, phenotypic heterogeneity is the consequence 
of noisy gene expression. Noise can be used also as a signal 
to trigger an epigenetic feedback loop when gene expres-
sion reaches a threshold [26]. Because this threshold is only 
reached in certain cells, the bacterial population splits into 
two cell types with distinct properties.
Subpopulation formation is observed at several stages of 
Salmonella infection, and may contribute to virulence attenu-
ation. For instance, synthesis and secretion of the Salmonella 
effectors necessary for epithelial cell invasion is restricted to a 
fraction of the bacterial population [2]. Salmonella entry into 
macrophages is also accompanied by formation of two sub-
populations, one of which replicates while the other enters a 
dormant-like state [21]. Like other bacterial species, Salmo-
nella also presents phenotypic heterogeneity generated by 
phase variation, the reversible switch of gene expression at 
high frequency (e.g., >10–5 per cell and generation) [39,40]. 
Switching turns gene expression from OFF to ON, or from 
low expression to high expression, and vice versa. An exam-
ple is the opvAB locus of Salmonella which controls O-anti-
gen chain length in the lipopolysaccharide [9]. Phase varia-
tion of opvAB generates two subpopulations, one with long 
O-antigen chains, another with shorter O-antigen chains. 
Fig. 2. Overgrowth of Salmonella enterica phoPQ mutants within eukaryotic 
cells. A. Intracellular growth rates (Ipro values) of wild type S. enterica 
(SL1344), a phoP mutant (SV4056), and a phoQ mutant (SV4365) in NRK 
fibroblasts and HeLa epithelial cells. Overgrowth is observed in fibro-
blasts and to a lesser extent in epithelial cells. B. Massive overgrowth of 
Salmonella phoP and phoQ mutants in NRK fibroblasts as observed by im-
munofluorescence microscopy. Monoclonal mouse IgG anti-LPS antibody 
and goat anti-mouse IgG conjugated to Texas Red were used for bacterial 
staining (red). DAPI (4,6-diamidino-2-phenyl-indole) was used to stain eu-
karyotic nuclei (blue). Arrows indicate wild type bacteria that do not ex-
hibit massive intracellular proliferation. Bar: 10 µm. (Reproduced from 
[6], © American Society for Microbiology, Infect. Immun. October 2001; 
doi:10.1128/IAI.69.10.6463-6474.2001).
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fection by Helicobacter resembles Salmonella chronic car-
riage in that both infections occur in hostile environments: 
the bile-laden gall bladder for Salmonella, the acid environ-
ment of the stomach for Helicobacter. An additional analogy 
is that in both cases latent infection permits shedding of 
bacteria and propagation to new hosts. Although the pres-
ence of Helicobacter in the stomach can cause ulcers and 
gastric cancer in certain individuals, epidemiologic studies 
suggest that latent infection with Helicobacter can protect 
against esophageal cancer [14].
Mycobacterium tuberculosis, the causal agent of tuberculo-
sis, is able to persist within humans for long periods without 
causing clinical symptoms of disease [25]. In Europe and the 
U.S., carriage affects at least 1% of the population, with enor-
mous regional differences. Chronic persistence of Mycobacte-
rium within the human host involves a state known as dor-
mancy: bacterial metabolism is slowed down and cell 
division is arrested [16]. Dormancy occurs in the vacuole of 
infected macrophages. Intracellular location of the pathogen, 
metabolic slowdown and cell division arrest make pharma-
cological treatment of dormancy useless. Unlike chronic in-
fection by Salmonella or Helicobacter, latent carriers of M. tu-
berculosis do not shed bacterial cells into the environment.
The view that primary pathogens and commensals are 
separated by a blurred line is further supported by epidemio-
logical evidence suggesting that reduction of human expo-
sure to infectious agents may have increased allergies and 
autoimmune diseases [14]. In fact, a widely accepted notion 
is that interaction with infectious agents, especially during 
infancy and childhood, may play a key role in development 
and tuning of the human immune system. If latent infections 
by human-adapted pathogens play beneficial protective 
roles, acute disease may be considered an accident triggered 
by factors that disrupt the host-pathogen equilibrium. As 
pointed out by Stanley Falkow, organisms like Helicobacter 
pylori, the typhoid bacillus, and Mycobacterium tuberculosis 
have been our constant companions through human evolu-
tion, and might be considered part of the normal human flo-
ra along with the accepted commensals [14].  
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